AlphaCrest Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,910
| Closed | -$1.71M | – | 1112 |
|
|
2022
Q3 | $1.71M | Sell |
5,910
-3,402
| -37% | -$985K | 0.1% | 287 |
|
|
2022
Q2 | $2.62M | Sell |
9,312
-4,303
| -32% | -$1.21M | 0.13% | 201 |
|
|
2022
Q1 | $3.55M | Sell |
13,615
-20,120
| -60% | -$5.25M | 0.2% | 93 |
|
|
2021
Q4 | $7.41M | Buy |
33,735
+2,115
| +7% | +$464K | 0.28% | 49 |
|
|
2021
Q3 | $5.74M | Sell |
31,620
-2,788
| -8% | -$506K | 0.3% | 37 |
|
|
2021
Q2 | $6.94M | Buy |
34,408
+18,021
| +110% | +$3.63M | 0.3% | 54 |
|
|
2021
Q1 | $3.52M | Buy |
16,387
+11,898
| +265% | +$2.56M | 0.2% | 118 |
|
|
2020
Q4 | $1.06M | Buy |
4,489
+724
| +19% | +$171K | 0.09% | 299 |
|
|
2020
Q3 | $1.03M | Sell |
3,765
-2,049
| -35% | -$558K | 0.11% | 251 |
|
|
2020
Q2 | $1.69M | Buy |
5,814
+2,052
| +55% | +$596K | 0.28% | 58 |
|
|
2020
Q1 | $895K | Buy |
3,762
+918
| +32% | +$218K | 0.11% | 318 |
|
|
2019
Q4 | $623K | Sell |
2,844
-13,138
| -82% | -$2.88M | 0.05% | 640 |
|
|
2019
Q3 | $2.71M | Buy |
15,982
+14,007
| +709% | +$2.37M | 0.16% | 143 |
|
|
2019
Q2 | $362K | Sell |
1,975
-1,573
| -44% | -$288K | 0.03% | 804 |
|
|
2019
Q1 | $653K | Buy |
+3,548
| New | +$653K | 0.1% | 359 |
|